Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds
- PMID: 37226415
- DOI: 10.1002/cyto.b.22133
Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds
References
REFERENCES
-
- Hamada, S., Jeannet, R., Gossez, M., Cour, M., Argaud, L., Francois, B., Daix, T., Venet, F., & Monneret, G. (2022). Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA-DR expression in clinical samples. Cytometry. Part B, Clinical Cytometry, 102(5), 384-389.
-
- Quadrini, K. J., Patti-Diaz, L., Maghsoudlou, J., Cuomo, J., Hedrick, M. N., & McCloskey, T. W. (2021). A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials. Cytometry. Part B, Clinical Cytometry, 100(1), 103-114.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials